Table 3.
ROI Analytic evaluation.
| ROI | 3M-O/HS-O1 | 3M-O/HS-O2 | 3M-N1/HS-N1 | 3M-N1/HS-N2 | 3M-N2/HS-N1 | 3M-N2/HS-N2 |
|---|---|---|---|---|---|---|
| Temporo-Parietal Right | 57.82% | 54.81% | 10.78% | 10.23% | 23.25% | 22.77% |
| Parietal | 68.92% | 45.61% | 66.30% | 74.88% | 73.48% | 80.24% |
| Temporo-Parietal Left | 47.01% | 54.58% | 10.99% | 29.73% | 29.63% | 44.44% |
| Central Right | 19.48% | 37.37% | −3.52% | 46.62% | −79.17% | 7.61% |
| Central | 57.82% | 89.46% | 0.95% | −13.04% | 25.93% | 15.46% |
| Central Left | 53.19% | 67.60% | 17.89% | 28.60% | −20.00% | −4.35% |
| Frontal Right | 40.38% | 34.71% | 33.33% | 39.13% | 35.90% | 41.47% |
| Frontal | 45.61% | 76.69% | 22.96% | −25.60% | 69.70% | 50.59% |
| Frontal Left | 49.81% | 58.67% | 35.00% | 27.78% | 16.67% | 7.41% |
Percentage difference, by ROIs, between the green regions (area of the power spectrum ≤ 4 Hz) in Figure 3 for subjects with 3M syndrome and control subjects. Data that exhibit concordant positive values are highlighted in orange.